Amitiza Approved for Opioid-Induced Constipation

Print Friendly, PDF & Email
Sucampo and Takeda announced that the FDA has approved the supplemental New Drug Application (sNDA) for Amitiza (lubiprostone) for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain.

Read Full Article from Source →

© Copyright 2013 Endoscopy Center. All Rights Reserved Privacy Policy | Site Map

Back to the Top